Asset management firm DBAY to buy UK's Alliance Pharma in $430 million deal

Reuters
2025.01.10 07:45
portai
I'm PortAI, I can summarize articles.

Britain's Alliance Pharma has agreed to be acquired by DBAY Advisors for £349.7 million ($429.6 million) in an all-cash deal, representing a 41% premium over its previous stock price. The acquisition is expected to finalize in the first half of 2025, with the Alliance board recommending shareholders support the deal. Alliance Pharma, which distributes healthcare products globally, recently experienced a leadership change and reported a 23% increase in pre-tax profit for the first half of the year.

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.